CD226 and cancer: When activating receptors, such as DNAM-1, NKG2D (Rae1δ in the murine system), and NKp46, bind to their ligands CD155 and MICA/B on cancer cells, it increases NK cell cytokine production, and further promotes cancer cell apoptosis [67,68].